ORAL CEREAL BETA GLUCAN COMPOSITIONS

(19)

(11)

EP 1 638 518 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	21.11.2012 Bulletin 2012/47

(45)	Mention of the grant of the patent:
	10.10.2012 Bulletin 2012/41

(21)	Application number: 04730426.6

(22)	Date of filing: 30.04.2004

(51)

International Patent Classification (IPC):

A61Q 11/00^(2006.01)

A61K 8/73^(2006.01)

(86)	International application number:
	PCT/CA2004/000661

(87)	International publication number:
	WO 2004/108103 (16.12.2004 Gazette 2004/51)

(54)	ORAL CEREAL BETA GLUCAN COMPOSITIONS ORALE ZUSAMMENSETZUNGEN AUF DER BASIS VON BETA GLUKAN AUS GETREIDEN COMPOSITIONS DE BETA-GLUCANE DE CEREALE DESTINEES A ETRE ADMINISTREES PAR VOIE ORALE

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30)

Priority:

10.06.2003 US 477048 P

(43)	Date of publication of application:
	29.03.2006 Bulletin 2006/13

(73)	Proprietor: Ceapro Inc.
	Edmonton, AB T5J 4P6 (CA)

(72)	Inventors:
	REDMOND, Mark, J. Edmonton, Alberta T6C 1B3 (CA) FIELDER, David, A. Edmonton, Alberta T6A 2S6 (CA)

(74)	Representative: Harding, Charles Thomas
	D Young & Co LLP 120 Holborn London EC1N 2DY London EC1N 2DY (GB)

(56)

References cited: :

EP-A- 1 066 823
WO-A-02/02645
WO-A-02/092028
US-A- 5 104 644
US-A1- 2002 054 917

WO-A-00/54739
WO-A-02/43719
WO-A-03/054077
US-A- 6 159 459
US-A1- 2003 091 516

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).